Daily News Podcast

TNF inhibitor linked to one-third drop in total mortality

Publish date: June 18, 2018

 

Receiving a TNF inhibitor for any indications cut patients’ overall mortality rate by more than one-third. Also today, HHS secretary, Alex Azar blames pharmacy benefit managers for no drop in prescription prices, a DEA ruling may have stoked illicit opioid sales, and taking a bisphosphonate holiday that lasts 2 years or longer is linked with increased risk for fracture.

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

Malnourished U.S. inpatients often go untreated
MDedge Internal Medicine
Suicide rate jumps 30%
MDedge Internal Medicine
New cell-free DNA assays hold promise for lung cancer screening
MDedge Internal Medicine
'Systemic changes' needed for bronchoscope disinfection
MDedge Internal Medicine
Allergies linked to autism spectrum disorder in children
MDedge Internal Medicine
Study finds widespread use of medications with depression as side effect
MDedge Internal Medicine
More from EuroPCR and Heart Rhythm
MDedge Internal Medicine
Type 2 diabetes may promote Parkinson development
MDedge Internal Medicine
Novel blood test that predicts gestational age, fetal development, could improve prenatal care
MDedge Internal Medicine
Routine AAA screening for older men: more harm than good?
MDedge Internal Medicine